QUOTE AND NEWS
Benzinga  Apr 19  Comment 
Akorn, Inc. (NASDAQ: AKRX) shares are drifting higher by 0.27 percent (about $0.10 per share) Wednesday after jumping 3.2 percent Tuesday following a report the company was on the verge of a buyout deal. Akorn shares jumped more than 3 percent...
Benzinga  Apr 11  Comment 
Last week, Fresenius Kabi, a subsidiary of Fresenius Medical Care AG & Co. (ADR) (NYSE: FMS) said it was looking into the possibility of acquiring Akorn, Inc. (NASDAQ: AKRX). Since the announcement, shares of the latter have spiked more than 30...
Motley Fool  Apr 10  Comment 
Management confirmed that it was in buyout talks with Fresenius Kabi for the potential sale of Akorn.
Benzinga  Apr 10  Comment 
A Bloomberg article Friday suggested that the European company Fresenius Medical Care AG & Co. (ADR) (NYSE: FMS) is considering a bid for Akorn, Inc. (NASDAQ: AKRX). While there is lack of certainty regarding whether such a deal would...
FiercePharma  Apr 10  Comment 
Fresenius in buyout talks with Akorn in bid to boost sterile injectables unit epalmer Mon, 04/10/2017 - 09:17
Benzinga  Apr 10  Comment 
IN THE NEWS BENZINGA Your local ATM could recognize your face within five years. Your taxes could be prepared by a robo-accountant. Your lawyer might be reduced to an algorithm fully versed in legal precedent: Link Akorn, Inc. (NASDAQ: AKRX)...
Benzinga  Apr 10  Comment 
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday, April 7 through Sunday, April 9, 2017. Fresenius in Talks for Acquisition of Akorn The Talks: Akorn, Inc. (NASDAQ: AKRX) confirmed a Bloomberg report...





You may also be interested in articles related to Akorn (AKRX):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki